opk – Scalper1

Opko Health Swallowing Bigger Fish Bio-Reference Labs

Opko Health (OPK) agreed to buy lab services company Bio-Reference Laboratories (BRLI) for $1.47 billion in stock Thursday. Bio-Reference shareholders will get 2.75 shares of Opko stock for each share held. Based on Opko’s closing price of 19.12 Wednesday, the 2.75-for-1 deal valued Bio-Reference at 52.58 a share. Opko stock hit a record high of 19.20 Wednesday. Opko stock, however, was near 17.75, down 7% in morning trading on the stock market

Pfizer Licenses Opko’s Long-Acting Growth Hormone

Biotech Opko Health found a big-pharma partner for its human-growth drug candidate in the form of Pfizer on Monday in a deal that could be worth as much as $570 million. Opko Health (OPK) stock was near 9, up 9% in morning trading — a more than three-month high — on the stock market today. The deal between Opko and Pfizer (PFE) concerns hGH-CTP, a long-acting form of human growth hormone (hGH) intended to treat adults and children with stunted